Abstract
The range of wavelengths used in ophthalmic photocoagulation treatment has been greatly enlarged by the development of the dye laser. To investigate the efficacy and possible side effects of orange dye laser light in the treatment of diabetic retinopathy, we performed a prospective, controlled clinical study comparing argon blue-green and orange dye laser light. In 14 patients with diabetic retinopathy of equal severity in both eyes one eye was randomly assigned to either blue-green argon (488 and 514.5 nm) or orange dye (600 nm) panretinal laser treatment. The total coagulated area was the same in both eyes. Subjective parameters (visual acuity, perimetry, color vision) as well as objective functions (electroretinography, electro-oculography) and the clinical course were studied preoperatively and then postoperatively over a period of 6 months. Dye laser coagulation proved as effective and safe as blue-green argon laser coagulation in the panretinal treatment of diabetic retinopathy. No significant differences in postoperative retinal function were detected. However, orange laser coagulation proved significantly more painful than bluegreen argon laser treatment (P=0.002).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Birch J (1985) Colour vision changes following different types of argon laser photocoagulation in the treatment of diabetic retinopathy. Doc Ophthalmol Proc Ser 46:199–208
Blankenship GW (1986) Red krypton and blue-green argon panretinal laser photocoagulation for proliferative diabetic retinopathy: a laboratory and clinical comparison. Trans Am Ophthalmol Soc 84:967–1003
Blankenship GW, Gerke E, Battle JF (1989) Red krypton and blue-green argon laser diabetic panretinal photocoagulation. Graefes Arch Clin Exp Ophthalmol 227:364–368
Cambie E (1983) Functional results following argon laser photocoagulation for diabetic retinopathy. In: Little HL, Jack RL, Patz A, Forsham PH (eds) Diabetic retinopathy. Thieme, Stuttgart, pp 274–284
Capoferri C, Bagini M, Chizzloi A, Pece A, Brancato R (1990) Electroretinographic findings in panretinal photocoagulation for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 228:232–236
Diabetic Retinopathy Study Research Group (1976) Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 81:383–396
Diabetic Retinopathy Study Research Group (1978) Photocoagulation treatment of proliferative diabetic retinopathy: the second report of Diabetic Retinopathy Study findings. Ophthalmology 85:1796–1806
Early Treatment Diabetic Retinopathy Study Research Group (1985) Photocoagulation for diabetic macular edema. ETDRS report no. 1. Arch Ophthalmol 103:1796–1806
François JA, De Renck A, Cambie E, Castanheira-Dinis A (1978) Electrophysiological studies before and after argon laser photocoagulation in diabetic retinopathy. Ophthalmologica 176:133–144
Frank RN (1975) Visual fields and electroretinography following extensive photocoagulation. Arch Ophthalmo 93: 591–598
Gerke E, Bornfeld N, Meyer-Schwickerath G (1985) Die Bedeutung der Lokalisation der Photokoagulationsherde bei der Therapie der proliferativen diabetischen Retinopathie. Fortschr Ophthalmol 82:109–111
Haut J, Brezin A, Lerner Y, Monin CL (1987) Is use of dye lasers justified, and the yellow radiation in particular? Ophthalmic Laser Ther 2:219–226
Körner F, Körner U (1988) Diabetische Retinopathie und Photokoagulation. Bücherei des Augenarztes. Beiheft der Klin Monatsbi Augenheilkd vol 114. Enke, Stuttgart
L'Esperance FA (1969) The ocular histiopathologic effect of krypton and argon laser radiation. Ophthalmology 68:263–273
Marshall J, Bird AC (1979) A comparative histopathological study of argon and krypton laser irridations of the human retina. Br J Ophthalmol 63:657–688
McDonald HR, Schatz H (1985) Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 92:388–393
Scherfig E, Krogh E (1981) EOG changes in photocoagulation in diabetic retinopathy. Acta Ophthalmol 59:917–920
Schulenburg WE, Hamilton AM, Blach RK (1979) A comparative study of argon and krypton laser in the treatment of diabetic optic disc neovascularisation. Br J Ophthalmol 63:412–417
Seiberth V, Alexandridis E, Feng W (1986) Netzhautfunktion nach panretinaler Laserkoagulation bei Retinopathia diabetica. Abhängigkeit von Größe und Dichte der Koagulationsherde. Fortschr Ophthalmol 83:463–466
Seiberth V, Alexandridis E, Feng W (1987) Function of the diabetic retina after panretinal argon laser coagulation. Graefes Arch Clin Exp Ophthalmol 225:385–390
Seiberth V, Alexandridis E (1991) Function of the diabetic retina after panretinal argon laser photocoagulation. Influence of the intensity of the coagulation spots. Ophthalmologica 202:10–17
Vogel M, Schäfer FP, Stuke M, Müller K, Theuring S, Morawitz A (1989) Animal experiments for the determination of an optimal wavelength for retinal coagulations. Graefes Arch Clin Exp Ophthalmol 227:277–280
Wade EC, Blankenship GW (1990) The effect of short versus long exposure times of argon laser panretinal photocoagulation on prioliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 228:226–231
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Seiberth, V., Schatanek, S. & Alexandridis, E. Panretinal photocoagulation in diabetic retinopathy: Argon versus dye laser coagulation. Graefe's Arch Clin Exp Ophthalmol 231, 318–322 (1993). https://doi.org/10.1007/BF00919027
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00919027